Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Combating Cancer With Natural Products What Would Non Coding Rnas Bring PDF full book. Access full book title Combating Cancer With Natural Products What Would Non Coding Rnas Bring.
| Author | : Yongye Huang |
| Publisher | : Frontiers Media SA |
| Total Pages | : 200 |
| Release | : 2021-11-05 |
| Genre | : Medical |
| ISBN | : 2889715965 |
| Author | : Yongye Huang |
| Publisher | : Frontiers Media SA |
| Total Pages | : 273 |
| Release | : 2023-03-15 |
| Genre | : Science |
| ISBN | : 2832517501 |
| Author | : Alfons Navarro |
| Publisher | : Humana |
| Total Pages | : 0 |
| Release | : 2022-06-25 |
| Genre | : Medical |
| ISBN | : 9781071615836 |
This volume presents techniques needed for the study of long non-coding RNAs (lncRNAs) in cancer from their identification to functional characterization. Chapters guide readers through identification of lncRNA expression signatures in cancer tissue or liquid biopsies by RNAseq, single Cell RNAseq, Phospho RNAseq or Nanopore Sequencing techniques; validation of lncRNA signatures by Real time PCR, digital PCR or in situ hybridization; and functional analysis by siRNA or CRISPR based methods for lncRNA silencing or overexpression. Lipid based nanoparticles for delivery of siRNAs in vivo, lncRNA-protein interactions, viral lncRNAs and circRNAs are also treated in this volume. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols. Authoritative and practical, Long Non-Coding RNAs in Cancer aims to provide a collection of laboratory protocols, bioinformatic pipelines, and review chapters to further research in this vital field.
| Author | : Iris F. F. Benzie |
| Publisher | : CRC Press |
| Total Pages | : 500 |
| Release | : 2011-03-28 |
| Genre | : Health & Fitness |
| ISBN | : 1439807167 |
The global popularity of herbal supplements and the promise they hold in treating various disease states has caused an unprecedented interest in understanding the molecular basis of the biological activity of traditional remedies. Herbal Medicine: Biomolecular and Clinical Aspects focuses on presenting current scientific evidence of biomolecular ef
| Author | : Huanfa Yi |
| Publisher | : Frontiers Media SA |
| Total Pages | : 247 |
| Release | : 2023-07-17 |
| Genre | : Medical |
| ISBN | : 2832529542 |
| Author | : Fazlul H. Sarkar |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 383 |
| Release | : 2011-11-22 |
| Genre | : Medical |
| ISBN | : 9400726309 |
This book is about Nutraceuticals in cancer therapy, specifically targeted and Adjuvant therapy. It shows several approaches for possibly reducing systemic toxicity. This book illustrates the role of several dietary agents, collectively called nutraceuticals or natural agents in the prevention and/or treatment of human malignancies known to be mediated through alterations in multiple molecular targets. This book contains sixteen chapters which begin with historical perspective on the value of natural agents in the prevention of human malignancies followed by a series of current topics on multiple nutraceuticals targeting multiple cancers. This collection would likely be useful for bringing newer generations with broader perspectives in launching cutting-edge innovative molecular research, which would certainly help in designing targeted clinical trials in order to realize the dream of customize strategies for the prevention and/or treatment of human malignancies without causing any systemic toxicity. Moreover, the knowledge gained would allow novel utilization of nutraceuticals as adjunct to both conventional chemotherapy and radiation therapy in order to improve the overall quality of life and survival of patients diagnosed with cancers.
| Author | : Donald Yance |
| Publisher | : McGraw Hill Professional |
| Total Pages | : 484 |
| Release | : 1999-10-02 |
| Genre | : Sports & Recreation |
| ISBN | : 9780879839680 |
In this text, herbalist and nutritionist, Donald Yance, shows how nutrition, herbal medicine, prayer and other forms of alternative medicine can heal and prevent cancer.
| Author | : Ayaz Shahid |
| Publisher | : Frontiers Media SA |
| Total Pages | : 353 |
| Release | : 2024-04-15 |
| Genre | : Science |
| ISBN | : 2832547842 |
Cancer is the second leading cause of death. Every year, many anticancer drug candidates are discovered and synthesized, but the major challenge lies in identifying, characterizing and evaluating their efficacy. The aim of this Research Topic, "New Mechanisms for Anti-Cancer Drugs" is to collect a group of publications focused on novel chemical compounds exhibiting new modes of actions and/or new target proteins to fulfill their cytotoxic activity on cancer cells. In this context, we will also be pleased to consider studies on drug repurposing, including approved, discontinued, and shelved drugs, when anti-cancer activity results from an unexpected mode of action.
| Author | : Deilson Elgui De Oliveira |
| Publisher | : Frontiers Media SA |
| Total Pages | : 185 |
| Release | : 2021-03-05 |
| Genre | : Science |
| ISBN | : 2889665658 |
| Author | : Aamir Ahmad |
| Publisher | : Springer Nature |
| Total Pages | : 427 |
| Release | : 2019-08-27 |
| Genre | : Medical |
| ISBN | : 3030203018 |
Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.
